![Denis Kay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Denis Kay
Fondatore presso
ALPHA COGNITION INC.
Profilo
Denis G.
Kay is the founder of Alpha Cognition, Inc., founded in 2000, serving as Chief Scientific Officer.
Dr. Kay is the founder of Neurodyn Life Sciences, Inc., founded in 2006, serving as Chief Scientific Officer.
Former job includes Director & Chief Scientific Officer at Neurodyn, Inc. Education includes a doctorate from McGill University and undergraduate and graduate degrees from Dalhousie University.
Posizioni attive di Denis Kay
| Società | Posizione | Inizio |
|---|---|---|
| ALPHA COGNITION INC. | Fondatore | 01/01/2000 |
Neurodyn Life Sciences, Inc.
 Neurodyn Life Sciences, Inc. BiotechnologyHealth Technology Engages in identifying, validating and developing of natural bioactives for the early treatment of neurological diseases | Fondatore | 01/08/2006 |
Precedenti posizioni note di Denis Kay
| Società | Posizione | Fine |
|---|---|---|
Neurodyn, Inc.
 Neurodyn, Inc. Pharmaceuticals: MajorHealth Technology Provides neurological diseases detection | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Denis Kay
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
20
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dalhousie University
 Dalhousie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neurodyn, Inc.
Neurodyn, Inc. Pharmaceuticals: MajorHealth Technology Provides neurological diseases detection | Health Technology |
Neurodyn Life Sciences, Inc.
Neurodyn Life Sciences, Inc. BiotechnologyHealth Technology Engages in identifying, validating and developing of natural bioactives for the early treatment of neurological diseases | Health Technology |
Alpha Cognition, Inc.
 Alpha Cognition, Inc. Financial ConglomeratesFinance Develops pharmaceutical products for treating neurodegenerative diseases | Finance |
